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Background: A primary objective in the treatment of patients with chronic obstructive pulmo-
nary disease (COPD) is to improve their health status.
Objective: To identify the factors associatedwith changes in health-relatedquality of life (HRQoL)
in patients with COPD after one year of follow-up in primary care.
Method: Multicenter, prospective study with one year of follow-up. The end-point was the change
in total score on the Saint George’s Respiratory Questionnaire (SGRQ). Patients with a clinically
relevant (>4 points) decrease or increase in SGRQ total score were compared. Factors associated
with thechanges inHRQoLobservedafter oneyearweredeterminedby logistic regressionanalysis.
Results: A total of 791patients (meanage, 70.2 years)were analyzed.MeanFEV1 (%predicted)was
52.4%. Average total SGQR score was 37.1 (SDZ 19.1) at baseline and 35.6 (SDZ 18.9) at follow-les Corts Catalanes, 587 A`tic, 08007 Barcelona, Spain. Tel.: þ34 93 4824604; fax: þ34 934824174.
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1590 M. Monteagudo et al.up. Significantly improvedHRQoLwas observed in 36.7% of patients, andwas associatedwith start-
ing polymedication, pulmonology visits, and balanced diet; ending respiratory rehabilitation, quit-
ting smoking; and not being a frequent exacerbator. Quality of life worsened significantly in 29.2%
of patients, and was associated with worsening respiratory symptoms and increased hospital ad-
missions.
Conclusions: Although overall changes in HRQoL observed after one yearwereminimal,more than
one third of patients improved significantly, and one third had significantly worse HRQoL. Clinical
factors were independently associated with these changes, emphasizing the relevance to
improvedHRQoL of starting a healthy lifestyle and respiratory treatments and the negative impact
on HRQoL of COPD symptoms onset and admissions.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is a common
health problem, with an estimated prevalence of 10.2% in
the general adult population of Spain.1 This chronic, pro-
gressive and debilitating disease is associated with deteri-
oration in health-related quality of life (HRQoL).2,3
One of the primary objectives in the treatment of pa-
tients with COPD is to improve and maintain their health
status by improving their symptoms, increasing functional
capacity, and preventing exacerbations.4 As a result, the
study of HRQoL in patients with COPD has become a topic of
growing interest.5,6
Although most patients with COPD are attended in the
primary care setting, most studies of COPD-related changes
in HRQoL have recruited hospitalized patients. These studies
report progressive deterioration in HRQoL related primarily
to worsening dyspnea, the presence of depression or anxiety
and a cumulative effect of exacerbations,7e10 but only a
weak association between HRQoL and changes in pulmonary
function.6,10,11 Given the differences in patient character-
istics and disease status, the results obtained in hospital
populations may not be generalizable to patients in primary
care. Two cross-sectional studies in primary care have
confirmed an impact on HRQoL at all stages of the disease3,4
and demonstrated a greater impact in patients with cough,
dyspnea, and longer duration of the disease.12 A longitudinal
study in primary care patients with COPD demonstrated the
negative impact of exacerbations on changes in HRQoL.13
Nonetheless, there is a lack of studies analyzing the fac-
tors that determine HRQoL changes in patients with COPD
followed prospectively in primary care.
The study objective was to describe changes in quality of
life in primary care patients with COPD after one year of
follow-up and identify factors that may influence the
improvement or worsening of HRQoL.Method
Study design and population
The present work was part of a multicenter, prospective
study with the objective of evaluating the effectiveness of
an integrated educational program directed at health
professionals and designed to improve quality of life and
clinical outcomes of their patients with COPD, after oneyear of follow-up. The study protocol14 and the impact of
the educational program were recently published.15
Briefly, 21 primary care centers recruited patients of
both sexes who met the following inclusion criteria: at least
40 years old, with a COPD diagnosis recorded in their clin-
ical history, and who had visited their physician during the
year before study inclusion. Exclusion criteria included
psychological problems, serious vision or hearing problems,
asthma, tuberculosis or other chronic respiratory diseases,
a terminal disease, or no telephone access.
The self-administered Saint George’s Respiratory Ques-
tionnaire (SGRQ), specifically designed to evaluate the
impact of chronic respiratory disease on HRQoL, was
completed by all participants. Scores range from 0 (no
deterioration or perfect health) to 100 (maximum effect or
worst possible state of health). A difference of at least 4
points in the SGRQ total score is considered a minimum
clinically important difference (MCID) from the patient’s
perspective.16 Based on the difference between the base-
line SGRQ total score and the score at the end of follow-up,
patients were categorized into 3 groups: (a) improving
HRQoL (>4 point decrease in SGQR total score), (b) wors-
ening HRQoL (>4 point increase in SGQR total score), and
(c) stable HRQoL (<4 point change in SGQR total score).
The Committee on Clinical Research and Ethics of the
Jordi Gol Institute for Primary Care Research (Barcelona,
Spain) approved the study. All patients provided written
informed consent to participate.
Data collection and sources
Data were collected from a review of clinical records and
from individual patient interviews.
A) Information gathered from clinical records:
Sociodemographic data, comorbidities, smoking habits,
follow-up spirometry (recorded in the clinical record during
routine monitoring of COPD in clinical practice over the year
preceding study inclusion), FEV1(%), number of exacerba-
tions, health care resources utilized, preventive activities and
treatment received during the year before study inclusion.
B) Information gathered from patient interviews:
Smoking habits, lifestyle habits, chronic respiratory
symptoms, hospital admissions during the year before study
Changes in quality of life of COPD patients 1591inclusion, dyspnea as measured by the Medical Research
Council (MRC) scale,17 and SGRQ score, using the validated
Spanish-language translation of the questionnaire.18 All
variables were collected at baseline and after 12 months.Statistical analysis
Descriptive statistics were used to summarize overall in-
formation. Categorical variables were expressed as number
(percentage), and continuous as mean (standard deviation)
or median (interquartile range). To identify the factors
significantly associated with changes in HRQoL, patient
characteristics were compared for those with a clinically
relevant change in SGRQ total score after one year of
follow-up. The differences within groups at baseline and
follow-up were assessed using independent or paired t-test,
Wilcoxon signed rank tests, chi squared test, and Fisher
exact or McNemar test for unadjusted comparisons, as
appropriate. At one-year follow-up, we assessed differ-
ences between the study groups in the changes observed.
To identify which clinical changes were independently
associated with improvement or worsening of patient
health during follow-up, logistic regression models were
constructed that had as their end point improvement vs all
other participants and worsening vs all other participants.
In the case of improved health, standard error (SE) was
adjusted by the cluster effect (EAP); because of variability
between primary care centers in patients with worsened
health, multilevel logistic models were constructed. The
variables considered were smoking habit, depression, ex-
ercise, diet, cough, expectoration, frequency of exacer-
bacions, doctor’s visits, nurse visits, pulmonologist visits,
respiratory rehabilitation, hospital admissions, poly-
medication, and adherence to treatment and to advice
provided about smoking, diet, and exercise. These vari-
ables were classified into 4 categories according to the
change from baseline at one year of follow-up: never (not
present at baseline or follow-up), incident (not present at
baseline but appeared during follow-up), remission (pre-
sent at baseline but disappeared during follow-up), and
persistent (present at baseline and during follow-up). In
addition, we considered the degree of dyspnea as contin-
uous variable and the assignment of the patient to the
educational program as dichotomous variable. All statistical
tests were two-sided at the 5% significance level. Analyses
were performed using Stata/SE version 11.1 for Windows
(Stata Corp. LP, College Station, Texas, US).Results
Characteristics of the population
Of the 801 patients who were eligible, 791 (98.7%)
completed the SGQR at baseline and at one year of follow-
up and were included in the analysis. In the study popula-
tion, the mean age was 70.2 years (standard deviation [SD]:
9.1), most were men (87.4%), mean duration of COPD was
7.7 years (SD: 5.8), and mean FEV1(%) was 52.3% (SD: 18.6%)
(Table 1).Changes in health-related quality of life
The mean total SGQR score was 37.1 (SD: 19.1) at baseline
and 35.6 (SD: 18.9) at one year of follow-up, which in-
dicates a mean of 1.5 point change in HRQoL. Although
this change was significant (p Z 0.016), it did not achieve
the clinical relevance defined as a change of more than 4
points in total SGQR score. At the end of follow-up, 290
patients (36.7%) had an improving quality of life and 231
patients (29.2%) had a worsening quality of life. The
remaining 270 patients (34.1%) had no clinically relevant
score change.
Baseline characteristics were comparable for patients in
both groups, except for respiratory rehabilitation, which
was more frequent in patients whose HRQoL improved
(Table 1).Factors associated with HRQoL changes in patients
with COPD after one year of follow-up
Among patients who had an improving HRQoL at one year of
follow-up, there was a significant increase in the percent-
age of patients taking multiple medications (14.8% in-
crease, p < 0.001) and in those who visited a pulmonologist
(11.1% increase). In addition to the importance of starting
these medical treatments, there were increases in influ-
enza vaccinations (7.6% increase, p < 0.01) and ex-smokers
(3.8% increase, p < 0.01), and a 4.2% decline in current
smokers, although the latter result was not significantly
different from the group with worsening HRQoL. A non-
significant increase in regular exercise in this group
differed significantly however (3.7%; p < 0.001) from the
group with worsening HRQoL (Table 2).
Patients with deterioration in HRQoL after one year of
follow-up had notably worsened symptoms, including a
significant increase in percentage of patients with coughing
(13.4%), expectoration (12.5%), and a significant increase in
hospital admissions (9.5%) and rehabilitation visits (3.9%)
compared to patients whose HRQoL was improving (Table 2;
Fig. 1). All comparisons were significant at the level of
p < 0.001. In addition, there was a direct relationship be-
tween changes in dyspnea measured by the MRC and sig-
nificant changes in HRQoL during the year of observation
(Fig. 2).
Regarding the use of healthcare resources, both groups
(improving or worsening HRQoL) had fewer doctor’s visits, a
more balanced diet, and more exacerbations at one year of
follow-up (Table 2).Identification of factors independently associated
with improving or worsening HRQoL
Factors significantly associated with improving HRQoL are
shown in Table 3. Initiation of pulmonology visits, poly-
medication, and a balanced diet; along with ending reha-
bilitation and quitting smoking; having a lower degree of
dyspnea and not being a frequent exacerbator were inde-
pendently and significantly associated with a higher prob-
ability of improvement in HRQoL after one year of follow-
up.
Table 1 Baseline characteristics of the patients included in the study according to the change in SGRQ total score at one year
of follow-up.
Variable Total
N Z 791
Improved HRQoL
decrease 4 SGRQ
n Z 290
Worsened HRQoL
increase 4 SGRQ
n Z 231
Sociodemographic characteristics
Age (years), mean (SD) 70.2 (9.1) 69.8 (8.09) 70.9 (9.3)
Sex: male 691 (87.4) 254 (87.6) 209 (90.5)
Education level
None 298 (37.7) 100 (34.5) 88 (38.1)
Primary 437 (55.2) 166 (57.2) 130 (56.3)
Other 56 (7.1) 24 (8.3) 13 (5.6)
Tobacco consumption
Non-smoker 115 (14.5) 46 (15.9) 24 (10.4)
Ex-smoker 521 (65.9) 189 (65.2) 166 (71.9)
Smoker 155 (19.6) 55 (19) 41 (17.7)
Comorbidities
Metabolic disease 579 (73.2) 210 (72.4) 172 (74.5)
Anxiety 81 (10.2) 28 (9.07) 29 (12.6)
Depression 95 (12) 27 (9.3) 32 (13.9)
Study group
Intervention 395 (49.9) 131 (45.2) 98 (42.4)
Control 396 (50.1) 159 (54.8) 133 (57.6)
Lifestyle
Balanced diet 586 (74.7) 217 (74.8) 173 (74.9)
Regular exercise 606 (77.1) 229 (79) 177 (76.6)
Years of COPD evolution, mean (SD) 7.7 (5.8) 7.47 (4.9) 8,1 (6.4)
FEV1 (% predicted); mean (SD) 52.3 (18.6) 53.8 (17.6) 48.8 (20.4)
Chronic symptoms
Dyspnea (MRC); mean(SD) 2.4 (1.1) 2.4 (1.1) 2.4 (1.1)
Cough 384 (48.5) 146 (50.3) 103 (44.6)
Sputum 442 (55.9) 165 (56.9) 121 (52.4)
Clinical progress
Patients with exacerbations 463 (58.5) 176 (60.7) 132 (57.1)
Exacerbations; median (interquartile range) 1 (0e2) 1 (0e1.25) 1 (0e1)
Frequent exacerbator (2 or more) 203 (25.7) 72 (24.8) 55 (23.8)
Patients admitted 92 (11.6) 31 (10.7) 26 (11.3)
Admissions; median (interquartile range) 1 (1e2) 1 (1e2) 1 (1e1)
Appointment
Primary care physician 748 (94.6) 276 (95.2) 216 (93.5)
Primary care nurse 275 (34.8) 99 (34.1) 66 (28.6)
Pulmonologist 236 (29.8) 81 (27.9) 79 (34.2)
Advice given to patients
Smoking cessation 179 (22.6) 59 (20.3) 48 (20.8)
Diet 151 (19.1) 58 (20) 43 (18)
Physical exercise 124 (15.7) 52 (17.9) 32 (13.9)
Influenza vaccinations 629 (79.5) 227 (78.3) 193 (83.5)
Chronic treatment
Multiple medications 689 (87.1) 255 (87.9) 205 (88.7)
Rehabilitation 28 (3.5) 16 (5.5) 2 (0.9)*
SGRQ, Saint George Respiratory Questionnaire; COPD, chronic obstructive pulmonary disease; SD, standard deviation; FEV1, forced
expired volume in one second; MRC, Medical Research Council. The data are n (%), unless otherwise indicated. *p < 0.01.
1592 M. Monteagudo et al.Factors significantly associated with worsening HRQoL
are shown in Table 4. An increase in symptoms (incidence of
expectoration and increased dyspnea) and hospital admis-
sions were independently and significantly associated with
a higher probability of worsening HRQoL after one year of
follow-up.Discussion
Our results indicate that patients with COPD attended by
primary care physicians have no relevant deterioration in
their HRQoL over one year, when considered globally;
however, there was a great variability at the individual
Table 2 Change within and between groups according to improvement or worsening of SGRQ scores. Values are %.
Variable Improving quality of
life. SGRQ  4 points
Worsening quality of
life. SGRQ  þ4 points
Differences between groups
Change % (follow-
up  baseline)
n Z 290
(95% CI) Change % (follow-
up  baseline)
n Z 231
95% CI (Degree of
improvement  degree
of worsening)a
(95% CI)
Tobacco use
Non-smoker 0.3 (0.67; 0.67) 0 (0.83; 0.83) 0.30 (0.32; 0.92)
Ex-smoker 3.8** (0.58; 5.75) 1.70 (1.04; 3.24) 2.10 (0.66; 4.86)
Smoker 4.2** (5.76; 1.06) 1.70 (3.24; 1.04) 2.50 (5.34; 0.34)
Depression/anxiety 1 (6.48; 4.41) 2.60 (8.93; 3.74) 1.60 (0.75; 3.95)
Lifestyle
Balanced diet 13.1*** (7.48; 18.71) 12.10*** (4.99; 16.93) 1 (4.72; 6.72)
Regular exercise 0.7 (4.36; 5.74) 3 (8.35; 2.26) 3.70*** (1.29; 6.10)
Symptoms
Dyspnea degree,
mean
0.15* (0.01; 0.28) 0.29*** (0.15; 0.43) 0.44*** (0.63; 0.24)
Cough 2 (8.61; 4.47) 13.40*** (6.48; 20.35) 15.40*** (20.07; 10.72)
Sputum 3.5 (9.55; 2.65) 12.50*** (5.69; 19.41) 16*** (20.76; 11.23)
Clinical progress
Patients with
exacerbations
13.4*** (9.07; 17.04) 15.20*** (9.95; 19.36) 1.80 (7.86; 4.26)
Exacerbations
(2 or more)
6.9** (2.08; 11.70) 8.70** (3.14; 14.17) 0.02 (6.46; 2.86)
No exacerbations,
mean
0.47*** (0.24; 0.68) 0.46*** (0.25; 0.66) 0.01 (0.29; 0.31)
Patients admitted 4.1** (1.55; 4.81) 9.50*** (5.37; 13.67) 5.40* (9.81; 0,98)
No admissions,
mean
0.23 (0.10; 0.57) 1.07*** (0.43; 1.68) 0.84* (1.56; 0.12)
Appointment
Primary care
physician
16.60*** (21.70; 11.40) 21.60*** (27.71; 15.57) 5 (1.81; 11.81)
Primary care nurse 2.50 (4.02; 8.85) 0.80 (6.13; 7.86) 1.70 (0.43; 3.83)
Pulmonologist 11.10*** (6.98; 14.32) 2.60 (0.47; 2.99) 8.50*** (4.34; 12.65)
Vaccinations
Influenza 7.60** (2.79; 12.38) 0.90 (3.62; 5.35) 6.70*** (3.41; 9.98)
COPD treatment
Multiple medications 14.80*** (9.77; 19.38) 6.10 (1.63; 10.48)** 8.7*** (0.04; 0.14)
Rehabilitation 1.40 (4.39; 1.63) 3.90* (0.83; 4.74) 5.30*** (8.13; 2.46)
COPD: chronic obstructive pulmonary disease; SGRQ: Saint George Respiratory Questionnaire.
*P < 0.05; **P < 0.01; ***P < 0.001.
a Change was 1-year follow-up minus baseline. Difference in SGRQ change: positive values correspond to the group with improving
HRQoL, negative values to worsening HRQoL.
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Figure 1 Relationship between change in SGRQ total score and change in respiratory symptoms at one year of follow-up.
1594 M. Monteagudo et al.level. One third (36.7%) of patients had clinically relevant
improvement in HRQoL, associated with starting poly-
medication, pulmonologist visits, and adherence to a
balanced diet; ending respiratory rehabilitation, quitting
smoking; and not being a frequent exacerbator. On the
other hand, nearly one third (29.2%) had worsening HRQoL,
associated with an increase in symptoms and in hospital
admissions.
Most studies of HRQoL deterioration over time in pa-
tients with COPD have been conducted in hospital pop-
ulations.8,19,20 In the primary care context, most studies
are cross-sectional and report a major HRQoL impact
among patients with COPD.3,12 Very few have assessed
HRQoL longitudinally; furthermore, they tend to focus on
acute exacerbations.13
In agreement with other studies in primary care,13 our
patients globally did not report a major deterioration in
HRQoL at one year of follow-up. Our results contrast with
those obtained in hospitalized patients, who had clinically
evident deterioration in HRQoL during follow-up.8,19 These
differences could be due to the hospital population’s gen-
eral characteristics, including more serious health prob-
lems, more comorbidities, and worse baseline HRQoL,Figure 2 Relationship between change in SGRQ total score and ch
definition at one year of follow-up.which could lead to more rapid decline in HRQoL. In addi-
tion, these studies are usually conducted over a longer time
period, which makes it easier to observe changes.
An important and innovative contribution of this study is
the identification of changes in clinical and treatment
factors that are associated with significant changes in
HRQoL.
It is known that rehabilitation improves dyspnea, exer-
cise capacity, and quality of life of patients with COPD.21
Interestingly, we observed a reduction in rehabilitation
visits associated with an improvement in HRQoL. We
postulate that patients left rehabilitation after experi-
encing an improvement in HRQoL, while worsening HRQoL
could have increased the indications for rehabilitation, in
accordance with current recommendations.21,22
In our results, smoking cessation has been associated
with HRQoL improvement. Tobacco use is considered an
important factor in the health status of patients with
COPD,23 leading to worse health in smokers vs ex-smokers
and non-smokers.19,24 Smoking cessation may have
contributed to symptoms improvement in our study par-
ticipants, particularly coughing and expectoration, thereby
at least partially explaining HRQoL improvement. Similarly,ange in degree of dyspnea per Medical Research Council (MRC)
Table 3 Independent factors associated with an improvement of SGRQ scores (>4 units) over one year of follow-up. Logistic
regression model.
Variable Estimated adjusted OR 95% confidence interval P-value in the model
Tobacco use (ref. persistent smoker) 4.66 1.67 12.97 0.003
Remission smoker
Diet (ref. never) 2.99 1.17 7.59 0.021
Incidence of healthy diet
Dyspnea degree 0.66 0.54 0.81 <0.001
Frequent exacerbator (ref. incidence) 2.06 1.31 3.22 0.002
Never
Visits to pulmonologist (ref. never) 2.998 1.42 5.85 0.003
Incidence of visits
Rehabilitation (ref. never) 4.73 1.45 15.40 0.010
Remission
Polymedication (ref. never) 3.32 2.01 5.48 <0.001
Incidence of polymedication
All ORs are adjusted for each variable presented in the Table.
Dyspnea degree as continuous.
Changes in quality of life of COPD patients 1595Hejidra et al.24 observed fewer respiratory symptoms in ex-
smokers and better HRQoL compared to current smokers.
We observed that more intense medical attention was
associated with improving HRQoL. Starting pulmonology
visits and polymedication, along with starting a balanced
diet, influenced improvements in patient health. This
contrasts with previous studies that associate the use of
multiple medications in treating COPD with a reduced
HRQoL for these patients.25,26 Nonetheless, there may be
an indication bias in these cross-sectional studies; it was
not possible to establish the order of causality.
On the other hand, patients with worse HRQoL had a
significant increase in respiratory symptoms and more
frequent hospital admissions.
Although the value of these factors as predictors of
worse HRQoL is well established,3,6,12,27,28 the present
study evaluated not only the presence of these character-
istics but also their incidence during the year of follow-up.
This study design allowed the observation that the inci-
dence of certain symptoms influenced HRQoL more than
their persistence. This may be the result of an adaptationTable 4 Independent factors associated with worsening SGRQ
regression model.
Variables Estimated adjusted OR
Group (ref. control) 0.61
Dyspnea degree 1.32
Expectoration (ref. never)
Incidence of expectoration
2.80
Visits to pulmonologist (ref. never)
Incidence of visits
0.26
Hospital admissions (ref. never)
Incidence of admissions
3.34
All ORs are adjusted for each variable presented in the Table.
Variance Z 0.32; SE Z 0.12.
Dyspnea degree as continuous.phenomenon: the patient adapts to persistent symptoms,
and so additional new symptoms would have a compara-
tively greater impact on quality of life.
Studies of the relationship between HRQoL and COPD
symptoms have identified dyspnea and, to a lesser extent,
chronic cough, expectoration, and wheezing as the factors
associated with a worse HRQoL.3,8,12,27 We have extended
these findings with the observation that onset of expecto-
ration and increased dyspnea were associated with a sig-
nificant worsening of HRQoL.
Some studies suggest that symptoms may constitute a
marker of inflammation and could help to identify an in-
flammatory phenotype in COPD.29,30 Our results point to-
ward possible links between increased symptoms, more
frequent exacerbations and hospitalizations, and worsening
in quality of life, perhaps mediated by or associated with
increased inflammation.
Independently of changes in HRQoL, we observed a
decline in visits to a family doctor during follow-up. Some
studies have described the limited use of health care by
individuals with chronic respiratory symptoms31; othersscores (>4 units) at one year of follow-up. Multilevel logistic
95% confidence interval P-value in the model
0.39 0.95 0.032
1.12 1.56 0.001
1.65 4.74 <0.001
0.11 0.63 0.003
1.69 6.61 0.001
1596 M. Monteagudo et al.highlight primary care professionals’ lack of familiarity with
treating this disease.32 However, the study design required
that all participating patients have at least one clinic visit
during the year preceding their inclusion. Approximately
30% of included patients did not suffer any exacerbation
during follow-up, so it’s likely they did not visit to their FP
because they perceived their disease as stable. If this were
the case, part of the observed reduction in medical visits
may have been an effect of the study design.
Exacerbations of COPD are a decisive factor in worsening
HRQoL.13,28,33 We observed a worsening HRQoL in patients
who experienced more exacerbations; however, patients
with improving HRQoL also had an increase in exacerbations.
Nonetheless, a significant association existed between not
being a frequent exacerbator and improvement in HRQoL.
This suggests that HRQoL improvement requires not only
fewer acute episodes but also their total prevention.
Our study has several limitations. We could not assess
the accuracy of the COPD diagnosis; however, the charac-
teristics of the included population very closely resembled
those of other series of patients with spirometrically
confirmed COPD. We evaluated only FEV1 because this
value is more frequently recorded in medical records and
classifies the severity of airflow obstruction and staging,
according to Global Initiative for Chronic Obstructive Lung
Disease stages. In the study population, the mean age was
70.2 years, most were men (87.4%) and mean duration of
COPD was 7.7 years. Although these characteristics are
representative of the primary care population of patients
with COPD in Spain,1,12,27 the extrapolation of the results to
other populations must be made with caution.
Another limitation of this study is the length of follow-
up. Longer follow-up can be expected to provide more in-
formation concerning the changes that patients experience
and their possible impact on quality of life. Nonetheless,
we were able to observe clinically important changes in
HRQoL in nearly two thirds of the study population (36.7%
improving and 29.2% worsening quality of life). Another
important limitation is that the study involved patients who
participated in a previously reported study to evaluate the
effectiveness of an educational intervention directed at
health professionals, with the goal of improving quality of
life and clinical outcomes of their patients with COPD.
Although in theory this could have affected the study re-
sults, the regression analysis was adjusted for participation
in the educational intervention.
Strengths of the study include its longitudinal design and
its primary care setting, with a very broad sample of patients
with different degrees of pulmonary involvement and stan-
dardized, systematic data collection by the research team.Conclusions
Although overall changes in HRQoL observed during one
year of follow-up were minimal, there was great variability
at the individual level. More than a third of patients had an
improvement in HRQoL at one year of follow-up, associated
with starting polymedication, pulmonology visits, and a
balanced diet; ending respiratory rehabilitation, quitting
smoking habit, and not being a frequent exacerbator.
Nearly one third had a worsening HRQoL after one year,associated with an increase in symptoms and hospital ad-
missions. Notably, the onset of new symptoms negatively
influenced HRQoL more than their persistence.
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